Log in to save to my catalogue

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacol...

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacol...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11770925

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacology and experimental verification

About this item

Full title

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacology and experimental verification

Publisher

England: BioMed Central Ltd

Journal title

BMC pharmacology & toxicology, 2025-01, Vol.26 (1), p.17, Article 17

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Renal fibrosis is crucial in the progression of chronic kidney disease (CKD) to end-stage renal failure. Geniposide, an iridoid glycoside, has shown therapeutic potential in acute kidney injury, diabetic nephropathy, and atherosclerosis. The aim of this study was to investigate the role of geniposide in renal fibrosis and its underlying mechanisms....

Alternative Titles

Full title

Analysis of the potential biological mechanisms of geniposide on renal fibrosis by network pharmacology and experimental verification

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11770925

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11770925

Other Identifiers

ISSN

2050-6511

E-ISSN

2050-6511

DOI

10.1186/s40360-025-00855-w

How to access this item